NeoGenomics beat analyst expectations on both the top and bottom lines. Adjusted EPS of $0.07 exceeded the consensus estimate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results